TP53 and cancer: Building on the proof-of-principle NF-κB screens, we performed four additional screens representing pathways that are broadly relevant not only to infection but also to cancer, inflammation, and development: p53 signaling, STING signaling, apoptosis, and MHC-I antigen presentation.